Gefinix
Gefinix is Gefitinib, an EGFR tyrosine kinase inhibitor. It is indicated for EGFR mutation-positive NSCLC and works by blocking EGFR-mediated tumor growth signaling.
Features
| Product Name | Gefinix |
| Generic Name | Gefitinib |
| Formulation | Tablet |
| Available Pack Size | 5X6's |
| Available Strength | 250MG |